hydroxyproline has been researched along with Pancreatitis, Chronic in 9 studies
Hydroxyproline: A hydroxylated form of the imino acid proline. A deficiency in ASCORBIC ACID can result in impaired hydroxyproline formation.
hydroxyproline : A proline derivative that is proline substituted by at least one hydroxy group.
Pancreatitis, Chronic: INFLAMMATION of the PANCREAS that is characterized by recurring or persistent ABDOMINAL PAIN with or without STEATORRHEA or DIABETES MELLITUS. It is characterized by the irregular destruction of the pancreatic parenchyma which may be focal, segmental, or diffuse.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Chronic pancreatitis was induced by continuous pancreatic ductal hypertension (PDH) for 14 days according to our previous study." | 5.37 | Treatment with pravastatin attenuates progression of chronic pancreatitis in rat. ( Harada, M; Otsuki, M; Wei, L; Yamamoto, M, 2011) |
| " The severity of fibrosis was determined by measuring hydroxyproline in pancreatic tissues and histological grading." | 3.79 | Antifibrotic role of chemokine CXCL9 in experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats. ( Chen, C; Gao, J; Han, W; Hu, G; Lu, H; Qian, L; Shen, J; Wan, R; Wang, X; Wu, M; Yu, Y; Zhu, S, 2013) |
| " Histological examination, Sirius red staining, and measurement of the contents of hydroxyproline and malondialdehyde of the pancreas were performed to evaluate pancreatic damage and fibrosis." | 3.77 | Comparison of antioxidative and antifibrotic effects of α-tocopherol with those of tocotrienol-rich fraction in a rat model of chronic pancreatitis. ( Du, YQ; Gao, J; Gong, YF; Gu, JJ; Hu, LH; Jiang, F; Li, ZS; Liao, Z; Man, XH, 2011) |
| "The mutant MCP-1 treated group inhibited early pancreatic inflammation and later pancreatic fibrosis histologically, and showed a decrease in serum MCP-1 concentration, intrapancreatic hydroxyproline, alpha-smooth muscle actin, and an increase in intrapancreatic amylase and protein content compared with the empty plasmid treated group." | 3.73 | Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats. ( Arita, Y; Egashira, K; Gibo, J; Ito, T; Kaku, T; Kawabe, K; Nawata, H; Oono, T; Usui, M; Zhao, HF; Zhao, QW, 2005) |
| "Chronic pancreatitis is a progressive inflammatory disease featuring irreversible irregular scarring of the exocrine parenchyma characterized by acinar destruction and fibrosis subsequent to inflammation in the pancreas." | 1.38 | Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in mice. ( Gao, J; Han, W; Qian, L; Shen, J; Wang, X; Wu, M; Xiang, D; Yang, L; Yu, Y; Zhang, J; Zhu, S, 2012) |
| "Chronic pancreatitis was induced by continuous pancreatic ductal hypertension (PDH) for 14 days according to our previous study." | 1.37 | Treatment with pravastatin attenuates progression of chronic pancreatitis in rat. ( Harada, M; Otsuki, M; Wei, L; Yamamoto, M, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 7 (77.78) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Shen, J | 4 |
| Gao, J | 3 |
| Chen, C | 1 |
| Lu, H | 1 |
| Hu, G | 1 |
| Zhu, S | 2 |
| Wu, M | 2 |
| Wang, X | 4 |
| Qian, L | 2 |
| Yu, Y | 2 |
| Han, W | 2 |
| Wan, R | 1 |
| Hou, XJ | 1 |
| Jin, ZD | 1 |
| Jiang, F | 2 |
| Zhu, JW | 1 |
| Li, ZS | 2 |
| Hu, Y | 1 |
| Sheng, Y | 1 |
| Yu, M | 1 |
| Li, K | 1 |
| Ren, G | 1 |
| Xu, X | 1 |
| Qu, J | 1 |
| Wei, L | 1 |
| Yamamoto, M | 1 |
| Harada, M | 1 |
| Otsuki, M | 1 |
| Liao, Z | 1 |
| Hu, LH | 1 |
| Du, YQ | 1 |
| Man, XH | 1 |
| Gu, JJ | 1 |
| Gong, YF | 1 |
| Zhang, J | 1 |
| Xiang, D | 1 |
| Yang, L | 1 |
| Krivoruchko, IA | 1 |
| Boĭko, VV | 1 |
| Zhukov, VI | 1 |
| Goncharova, NN | 1 |
| Andreeshchev, SA | 1 |
| Moiseenko, AS | 1 |
| Okamoto, T | 1 |
| Yamada, T | 1 |
| Kuno, A | 1 |
| Ogawa, K | 1 |
| Tang, M | 1 |
| Sano, H | 1 |
| Ohara, H | 1 |
| Nakao, H | 1 |
| Kataoka, H | 1 |
| Shirai, T | 1 |
| Itoh, M | 1 |
| Zhao, HF | 1 |
| Ito, T | 1 |
| Gibo, J | 1 |
| Kawabe, K | 1 |
| Oono, T | 1 |
| Kaku, T | 1 |
| Arita, Y | 1 |
| Zhao, QW | 1 |
| Usui, M | 1 |
| Egashira, K | 1 |
| Nawata, H | 1 |
9 other studies available for hydroxyproline and Pancreatitis, Chronic
| Article | Year |
|---|---|
Antifibrotic role of chemokine CXCL9 in experimental chronic pancreatitis induced by trinitrobenzene sulfonic acid in rats.
Topics: Animals; Antibodies, Neutralizing; Cell Proliferation; Chemokine CXCL9; Collagen Type I; Fibrosis; H | 2013 |
Expression of Smad7 and Smad ubiquitin regulatory factor 2 in a rat model of chronic pancreatitis.
Topics: Actins; Animals; Blotting, Western; Hydroxyproline; Male; Organotin Compounds; Pancreas; Pancreatic | 2015 |
Antioxidant activity of Inonotus obliquus polysaccharide and its amelioration for chronic pancreatitis in mice.
Topics: Amylases; Animals; Antioxidants; Basidiomycota; Body Weight; Cytokines; Fungal Polysaccharides; Hydr | 2016 |
Treatment with pravastatin attenuates progression of chronic pancreatitis in rat.
Topics: Analysis of Variance; Animals; Fibrosis; Hydroxyproline; Immunohistochemistry; Interleukin-10; Male; | 2011 |
Comparison of antioxidative and antifibrotic effects of α-tocopherol with those of tocotrienol-rich fraction in a rat model of chronic pancreatitis.
Topics: Actins; Administration, Oral; alpha-Tocopherol; Animals; Anti-Inflammatory Agents; Antioxidants; Apo | 2011 |
Recombinant human interleukin-1 receptor antagonist (rhIL-1Ra) attenuates caerulein-induced chronic pancreatitis in mice.
Topics: Amylases; Animals; Ceruletide; Collagen; Disease Models, Animal; Fibrosis; Humans; Hydroxyproline; I | 2012 |
[Methabolism of connective tissue in patients with complicated chronic pancreatitis].
Topics: Adult; Collagen; Connective Tissue; Female; Fibrosis; Glycosaminoglycans; Humans; Hydroxyproline; Ma | 2011 |
FTY720, an immunosuppressant, attenuates chronic pancreatitis in rats by suppressing T-cell infiltration.
Topics: Animals; Body Weight; Fingolimod Hydrochloride; Hydroxyproline; Immunosuppressive Agents; Interferon | 2005 |
Anti-monocyte chemoattractant protein 1 gene therapy attenuates experimental chronic pancreatitis induced by dibutyltin dichloride in rats.
Topics: Actins; Animals; Blotting, Western; Chemokine CCL2; Chemokines; Cytokines; Disease Models, Animal; D | 2005 |